Organo-ID
1 known investors
ORGANO-ID develops patient-derived organoid technology to enable precision cancer therapy testing, creating functional tissue models from tumor biopsies to predict individual drug responses for personalized treatment planning. The company focuses on colorectal carcinoma and aims to expand its organoid-based diagnostic platform across multiple cancer types.
BiotechDigital HealthMedical Devicesin /organo-id-bi%CC%87yoteknoloji%CC%87-laboratuvar-hi%CC%87zmetleri%CC%87-sanayi%CC%87-ve-ti%CC%87caret-anoni%CC%87m-%C5%9Fi%CC%87rketi%CC%87
Founders & leadership
PD
Prof. Dr. Erdal